Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Semantics, ChemAxon Ink Software Integration Agreement


Cambridge Semantics said this week that it has signed a software integration agreement with ChemAxon that will allow it to integrate the latter's search and visualization capabilities into its Anzo software.

The agreement will provide Anzo customers with tools to search for chemical structures by directly drawing substructures as well as the ability to visualize chemical structures within their Anzo web dashboards. They'll also be able to easily integrate other sources of information with their chemical structure data.

The combined solution will be "a huge benefit to global pharma companies as well as major chemical and agrochemistry companies, biotech enterprises, and academic research centers," Alex Drijver, ChemAxon's CEO, said in a statement.

Pharma customers, for example, could use it to "more easily find all of the papers related to a particular chemical substructure in patent information, publications and other drug research databases," according to Lee Feigenbaum, co-founder and vice president of marketing and technology for Cambridge Semantics. It could also, for instance, help a customer "better locate biotech companies developing an asthma drug in phase 1 or 2 of development that has an active compound matching a particular chemical substructure," he said.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.